Skip to content

Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation

Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation - an Open, Randomised Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00536926
Acronym
TeleTx
Enrollment
56
Registered
2007-09-28
Start date
2007-07-31
Completion date
2009-07-31
Last updated
2011-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Transplantation

Keywords

telemedicine, lung transplantation, home spirometry

Brief summary

In an investigation should be evaluated in contrast to a control group with standard post-treatment therapy (using home spirometry) after lung transplantation if transfer of home spirometry recordings to the transplant center via cell phones will lead to less complications, cost savings and bigger constancy of therapy.

Detailed description

Home spirometry is used as a standard of care in lung transplant recipients in many centers worldwide. In case of deteriorating lung function response until therapy depends on patients efforts to reach the transplant center and the contactability of the transplant center. Therefore transfer of home spirometry recordings to the transplant center via cell phones will lead to less complications, cost savings and bigger constancy of therapy compared to the home spirometry alone.

Interventions

DEVICEHome spirometry with data transfer via cell phone

home spirometry recording

DEVICEHome spirometer with BT-cellphone

Data transfer of home spirometry recordings via bluetooth to clinical database.

DEVICEHome spirometer w/o BT

Standard home spirometry

Sponsors

Corscience, Inc.
CollaboratorINDUSTRY
Hannover Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients after lung transplantation (single and double lung transplantation incl. combined organ transplantation) before hospital discharge

Exclusion criteria

* Dependency on long term care * Restricted ability to communicate

Design outcomes

Primary

MeasureTime frame
Adherence6 months

Secondary

MeasureTime frame
Latency: symptom onset to transplant team contact patient contacts emergency visits hospitalisations6 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026